• English
  • Sign In
  • Contact Us
×
Catalog Products » Other Products » Catalog Peptides » Catalog Peptides - Hot Products » OVA Peptide (257-264)

OVA Peptide (257-264)

Description This is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.
Sequence
{SER}{ILE}{ILE}{ASN}{PHE}{GLU}{LYS}{LEU}
Sequence Shortening SIINFEKL
Molecular Formula C45H74N10O13
Molecular Weight 963.13

Purity 95%
Solubility The peptide was water soluble on vortexing. May be dissolved in any buffer of pH <6.
Anaspec Cat No Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu
Storage Store at -20°C.
Note

  • OVA Peptide (257-264)
  • OVA Peptide (257-264)


Cat. No.
Product Name
Price
RP10610-5
OVA Peptide (323-339) - 5 mg
$418.00
RP10610-1
OVA Peptide (323-339) - 1 mg
$104.00
 
Mayerova D, et al. Conditioning of langerhans cells induced by a primary CD8 T cell response to self-antigen in vivo. J. Immunol. Apr 2006; 176(8): 4658-4665.

Saunderson SC., et al. CD169 mediates the capture of exosomes in spleen and lymph node. Blood. 2014 Jan;123(2):208-16.

de Titta A., et al. Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose. Proc Natl Acad Sci U S A. 2013 Dec;110(49):19902-7.

Molino NM., et al. Biomimetic Protein Nanoparticles Facilitate Enhanced Dendritic Cell Activation and Cross-Presentation. ACS Nano. 2013 Nov;7(11):9743-52..

Pinelli DF., et al. An Anti‐CD154 Domain Antibody Prolongs Graft Survival and Induces Foxp3 iTreg in the Absence and Presence of CTLA‐4 Ig. Am J Transplant. 2013 Nov;13(11):3021-30.

Flórido M., et al. Influenza A Virus Infection Impairs Mycobacteria-Specific T Cell Responses and Mycobacterial Clearance in the Lung during Pulmonary Coinfection. J Immunol. 2013 Jul;191(1):302-11.

Liu D., et al. Inhibition of CD8 T Cell–Derived CD40 Signals Is Necessary but Not Sufficient for Foxp3 Induced Regulatory T Cell Generation In Vivo. J Immunol. 2013 Aug;191(4):1957-64.

Wensveen FM., et al. NKG2D Induces Mcl-1 Expression and Mediates Survival of CD8 Memory T Cell Precursors via Phosphatidylinositol 3-Kinase. J Immunol. 2013 Aug;191(3):1307-15..

Kazuhito Kawata., et al. Clonality, activated antigen specific CD8 T cells and development of autoimmune cholangitis in dnTGFβRII mice. Hepatology. 2013 Sep;58(3):1094-104.

Stephan Kontos., et al. Engineering Antigens For In Situ Erythrocyte Binding Induces T-Cell Deletion. Proc Natl Acad Sci U S A. 2013 Jan;110(1):E60-8.

Hamilton MJ., et al. Macrophages Are More Potent Immune Suppressors Ex Vivo Than Immature Myeloid-Derived Suppressor Cells Induced by Metastatic Murine Mammary Carcinomas. J Immunol. 2014 Jan;192(1):512-22.

Stano A., et al. Tunable T cell immunity towards a protein antigen using polymersomes vs. solid-core nanoparticles. Biomaterials. 2013 Jun;34(17):4339-46.

François P., et al. Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism. Proc Natl Acad Sci U S A. 2013 Mar;110(10):E888 - E897.

Kei Tomihara., et al. Aging‐associated B7‐DC B cells enhance anti‐tumor immunity via Th1 and Th17 induction. Aging Cell. 2012 Feb;11(1):128-38.

Cheng C., et al. Multifunctional triblock copolymers for intracellular messenger RNA delivery. Biomaterials. 2012 Qct;33(28):6868-76.

Ratikan JA., et al. Chloroquine Engages the Immune System to Eradicate Irradiated Breast Tumors in Mice. Int J Radiat Oncol Biol Phys. 2013 Qct;87(4):761-8.

Xiang SD., et al. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers. Methods. 2013 May;S1046-2023(13):00121 - 7.

Laird RM., et al. γδ T cells acquire effector fates in the thymus and differentiate into cytokine-producing effectors in a listeria model of infection independently of CD28 costimulation. PLoS One. 2013 Ap

Bachy V., et al. Langerin negative dendritic cells promote potent CD8 T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci U S A. 2013 Feb;110(8):3041 - 6.

Cremel M., et al. Red blood cells as innovative antigen carrier to induce specific immune tolerance. Int J Pharm. 2013 Feb;443(1-2):39-49.

K Perica et al Transient Combination Therapy Targeting the Immune Synapse Abrogates T Cell Responses and Prolongs Allograft Survival in Mice. Nanomedicine 2013 Jul;

You can visit "Citations Database" for more citations.







For more documents, please visit "Technical Support".

Cat. No. RP10611
Size
Price
1 mg $62.00